ReviewFrontiers in oncology2026
Advances in polyphenol-based strategies for musculoskeletal recovery and exercise rehabilitation in cancer: Mechanistic insights into Wnt/β-catenin and PI3K/Akt signaling pathways and inflammatory markers.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Musculoskeletal dysfunction and compromised physical performance are prevalent complications observed in individuals diagnosed with cancer, frequently intensified by the administration of chemotherapy, radiotherapy, and extended periods of physical inactivity. Polyphenols (bioactive constituents derived from various plant sources) have exhibited significant anti-inflammatory, antioxidant, and anti-apoptotic characteristics that may serve to augment exercise interventions aimed at improving musculoskeletal recovery and rehabilitation outcomes. This review encapsulates the existing preclinical and clinical evidence regarding the synergistic effects of polyphenol supplementation in conjunction with structured exercise protocols in the context of cancer, with particular emphasis on underlying molecular mechanisms and functional outcomes. Prominent signaling pathways influenced by these combined therapeutic strategies include Wnt/β-catenin, PI3K/Akt, TNF-α/NF-κB, IL-4/STAT6, and TGF-β1/TRAF6, which are integral to the regulation of inflammation, apoptosis, muscle metabolism, and tissue remodeling. Preclinical investigations conducted using rodent cancer models consistently reveal that polyphenols such as curcumin, resveratrol, and genistein, significantly enhance the efficacy of both aerobic and resistance exercise concerning tumor suppression, muscle preservation, and modulation of molecular pathways. Clinical evidence, although scarce, suggests potential enhancements in muscular strength, endurance, and recovery when polyphenolic compounds are utilized in conjunction with exercise rehabilitation, particularly among individuals undergoing oncological treatment. Despite these encouraging results, variability in dosing regimens, formulations, timing, and participant demographics constrains the generalizability of the findings. Subsequent research endeavors should prioritize the development of standardized polyphenolic preparations, refined exercise protocols, and clinically relevant functional outcomes to establish evidence-based clinical guidelines. The integration of polyphenols with exercise represents an auspicious non-pharmacological approach to augment musculoskeletal function and enhance quality of life in the context of cancer rehabilitation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.